Delivery Order SPE2DB20D2104-SPE2DB25FMLKG
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,162.26, is for the delivery of granisetron HCL 1 mg tablet units. It is a firm fixed-price delivery order contract with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,564.18 firm fixed price delivery order is for the supply of 4,564,094,914 units of the medication Granisetron HCL 1 mg Tablet UD 20s. This award is associated with Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Granisetron Hydrochloride 1 mg Tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,346.21, and has an ultimate completion date of October 19, 2023. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,810.72 firm fixed-price delivery order is for the supply of granisetron HCL 1 mg tablets, with a period of performance through October 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,932.26, is a delivery order for the supply of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6RKK, is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,771.41 firm fixed-price contract is for the delivery of 4,565,334,284 units of the drug Granix 300 MCG TBO. This award is not set aside and is part of Amerisourcebergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,204.32 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,495.59, is a Firm Fixed Price Delivery Order for the supply of 4567254281 ONDANSETRON HCL 4 MG TABLET 30S. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,487.64, is a delivery order for the supply of 4562924631 - ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of November 29, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,330.64 firm fixed-price delivery order contract is for the supply of Gralise ER 600 mg tablets. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...